• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于生理的药代动力学模型对模型参数变化的敏感性:二氯甲烷

Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride.

作者信息

Clewell H J, Lee T S, Carpenter R L

机构信息

Clement Associates, Ruston, Louisiana.

出版信息

Risk Anal. 1994 Aug;14(4):521-31. doi: 10.1111/j.1539-6924.1994.tb00268.x.

DOI:10.1111/j.1539-6924.1994.tb00268.x
PMID:7972956
Abstract

The parameters in a physiologically based pharmacokinetic (PBPK) model of methylene chloride were varied systematically, and the resulting variation in a number of model outputs was determined as a function of time for mice and humans at several exposure concentrations. The importance of the various parameters in the model was highly dependent on the conditions (concentration, species) for which the simulation was performed and the model output (dose surrogate) being considered. Model structure also had a significant impact on the results. For sensitivity analysis, particular attention must be paid to conservation equations to ensure that the variational calculations do not alter mass balance, introducing extraneous effects into the model. All of the normalized sensitivity coefficients calculated in this study ranged between -1.12 and 1, and most were much less than 1 in absolute value, indicating that individual input errors are not greatly amplified in the outputs. In addition to ranking parameters in terms of their impact on model predictions, time-dependent sensitivity analysis can also be used as an aid in the design of experiments to estimate parameters by predicting the experimental conditions and sampling points which will maximize parameter identifiability.

摘要

对二氯甲烷基于生理的药代动力学(PBPK)模型中的参数进行了系统变化,并确定了在几种暴露浓度下,小鼠和人类的一些模型输出随时间变化的结果。模型中各个参数的重要性高度依赖于进行模拟的条件(浓度、物种)以及所考虑的模型输出(剂量替代指标)。模型结构对结果也有显著影响。对于敏感性分析,必须特别注意守恒方程,以确保变分计算不会改变质量平衡,从而不会将无关效应引入模型。本研究中计算的所有归一化敏感性系数介于 -1.12 和 1 之间,且大多数绝对值远小于 1,这表明单个输入误差在输出中不会被大幅放大。除了根据参数对模型预测的影响进行排序外,时间依赖性敏感性分析还可用于辅助实验设计,通过预测能使参数可识别性最大化的实验条件和采样点来估计参数。

相似文献

1
Sensitivity of physiologically based pharmacokinetic models to variation in model parameters: methylene chloride.基于生理的药代动力学模型对模型参数变化的敏感性:二氯甲烷
Risk Anal. 1994 Aug;14(4):521-31. doi: 10.1111/j.1539-6924.1994.tb00268.x.
2
PBPK modeling/Monte Carlo simulation of methylene chloride kinetic changes in mice in relation to age and acute, subchronic, and chronic inhalation exposure.二氯甲烷在小鼠体内与年龄以及急性、亚慢性和慢性吸入暴露相关的动力学变化的生理药代动力学(PBPK)建模/蒙特卡罗模拟
Environ Health Perspect. 1996 Aug;104(8):858-65. doi: 10.1289/ehp.96104858.
3
Sensitivity analysis for physiologically based pharmacokinetic models.
J Pharmacokinet Biopharm. 1991 Feb;19(1):1-20. doi: 10.1007/BF01062190.
4
Evaluation of three physiologically based pharmacokinetic (PBPK) modeling tools for emergency risk assessment after acute dichloromethane exposure.三种基于生理的药代动力学(PBPK)建模工具用于急性二氯甲烷暴露后应急风险评估的评价
Toxicol Lett. 2015 Jan 5;232(1):21-7. doi: 10.1016/j.toxlet.2014.10.010. Epub 2014 Oct 13.
5
Revised assessment of cancer risk to dichloromethane: part I Bayesian PBPK and dose-response modeling in mice.二氯甲烷癌症风险的修订评估:第一部分 小鼠中的贝叶斯PBPK和剂量反应模型
Regul Toxicol Pharmacol. 2006 Jun;45(1):44-54. doi: 10.1016/j.yrtph.2005.12.007. Epub 2006 Jan 25.
6
The impact of exercise and intersubject variability on dose estimates for dichloromethane derived from a physiologically based pharmacokinetic model.
Fundam Appl Toxicol. 1994 Jan;22(1):20-5. doi: 10.1006/faat.1994.1003.
7
A trichloroethylene risk assessment using a Monte Carlo analysis of parameter uncertainty in conjunction with physiologically-based pharmacokinetic modeling.一项使用蒙特卡罗分析参数不确定性并结合基于生理学的药代动力学模型的三氯乙烯风险评估。
Risk Anal. 1995 Oct;15(5):555-65. doi: 10.1111/j.1539-6924.1995.tb00752.x.
8
Assessing drug distribution in tissues expressing P-glycoprotein using physiologically based pharmacokinetic modeling: identification of important model parameters through global sensitivity analysis.使用基于生理的药代动力学模型评估表达 P-糖蛋白的组织中的药物分布:通过全局敏感性分析确定重要模型参数。
J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):495-522. doi: 10.1007/s10928-009-9134-8. Epub 2009 Oct 22.
9
Effects of glutathione transferase theta polymorphism on the risk estimates of dichloromethane to humans.谷胱甘肽转移酶θ基因多态性对二氯甲烷对人类风险评估的影响。
Toxicol Appl Pharmacol. 1999 Aug 1;158(3):221-30. doi: 10.1006/taap.1999.8715.
10
Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.用于毒理学和风险评估的基于生理的药代动力学和基于生理的药效学模型的开发。
Toxicol Lett. 1995 Sep;79(1-3):35-44. doi: 10.1016/0378-4274(95)03355-o.

引用本文的文献

1
Bayesian inference informed by parameter subset selection for a minimal PBPK brain model.基于参数子集选择的最小化生理药代动力学脑模型的贝叶斯推断
Philos Trans A Math Phys Eng Sci. 2025 Mar 13;383(2292):20240219. doi: 10.1098/rsta.2024.0219.
2
A physiologically-based pharmacokinetic model of oseltamivir phosphate and its carboxylate metabolite for rats and humans.磷酸奥司他韦及其羧酸盐代谢物在大鼠和人类中的生理药代动力学模型。
ADMET DMPK. 2019 Feb 23;7(1):22-43. doi: 10.5599/admet.628. eCollection 2019.
3
Current Approaches and Techniques in Physiologically Based Pharmacokinetic (PBPK) Modelling of Nanomaterials.
纳米材料基于生理的药代动力学(PBPK)建模的当前方法和技术
Nanomaterials (Basel). 2020 Jun 29;10(7):1267. doi: 10.3390/nano10071267.
4
Estimating Methylmercury Intake for the General Population of South Korea Using Physiologically Based Pharmacokinetic Modeling.应用生理药代动力学模型估算韩国普通人群的甲基汞摄入量。
Toxicol Sci. 2017 Sep 1;159(1):6-15. doi: 10.1093/toxsci/kfx111.
5
Physiologically based pharmacokinetic modeling of tea catechin mixture in rats and humans.大鼠和人体中茶儿茶素混合物的生理药代动力学建模
Pharmacol Res Perspect. 2017 Apr 17;5(3):e00305. doi: 10.1002/prp2.305. eCollection 2017 Jun.
6
Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.基于生理的吸收模型在表征成人口服缓释哌醋甲酯产品药代动力学特征中的应用。
PLoS One. 2016 Oct 10;11(10):e0164641. doi: 10.1371/journal.pone.0164641. eCollection 2016.
7
Dietary Iodine Sufficiency and Moderate Insufficiency in the Lactating Mother and Nursing Infant: A Computational Perspective.哺乳期母亲和哺乳婴儿的膳食碘充足与轻度不足:计算视角
PLoS One. 2016 Mar 1;11(3):e0149300. doi: 10.1371/journal.pone.0149300. eCollection 2016.
8
Development of a physiologically based model to describe the pharmacokinetics of methylphenidate in juvenile and adult humans and nonhuman primates.开发一种基于生理学的模型,以描述哌甲酯在青少年、成年人及非人灵长类动物体内的药代动力学。
PLoS One. 2014 Sep 3;9(9):e106101. doi: 10.1371/journal.pone.0106101. eCollection 2014.
9
Differential pharmacokinetic analysis of in vivo erythropoietin receptor interaction with erythropoietin and continuous erythropoietin receptor activator in sheep.绵羊体内促红细胞生成素受体与促红细胞生成素和持续型促红细胞生成素受体激活剂相互作用的药代动力学差异分析。
Biopharm Drug Dispos. 2011 Jul;32(5):276-88. doi: 10.1002/bdd.757. Epub 2011 Jun 15.
10
A Bayesian population PBPK model for multiroute chloroform exposure.多途径氯仿暴露的贝叶斯群体 PBPK 模型。
J Expo Sci Environ Epidemiol. 2010 Jun;20(4):326-41. doi: 10.1038/jes.2009.29. Epub 2009 May 27.